SCHEMBL6766674

SCHEMBL6766674

COc1cccc(-n2nc(C(C)(C)C)c3c2CC(C(C)C)CC3=O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK2 O43353 1/20 0.46
MAPT P10636 5/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
ALPG P10696 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
DHODH Q02127 1/20 0.37
MGLL Q99685 1/20 0.37
MAPK13 O15264 1/20 0.36
MAPK12 P53778 1/20 0.36
MAPK11 Q15759 1/20 0.36
MAPK14 Q16539 1/20 0.36
CCR1 P32246 1/20 0.36
RAB9A P51151 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
KMT2A Q03164 3/20 0.36
HTT P42858 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CASP1 P29466 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6770539 0.87 SRC (0.39) ALDH1A1HPGDDHODHSMN1; SMN2KMT2A
SCHEMBL6770505 0.87 OPRM1 (0.46) MAPTNPSR1DHODHMGLLRAB9A
SCHEMBL6766708 0.86 RIPK2 (0.48) RIPK2MAPTALDH1A1HPGDNPSR1
SCHEMBL6164978 0.86 DHODH (0.41) ALDH1A1DHODHMAPK13MAPK12MAPK11
SCHEMBL6777339 0.85 CASP1 (0.39) MAPTALDH1A1HPGDNPSR1DHODH
SCHEMBL6772551 0.84 DHODH (0.37) RIPK2MAPTALDH1A1HPGDNPSR1
SCHEMBL6770575 0.84 GPBAR1 (0.39) MAPTDHODHMGLLRAB9ASMN1; SMN2
SCHEMBL6770636 0.84 RIPK2 (0.35) RIPK2MAPTDHODHMGLLCCR1
SCHEMBL6766574 0.82 ALDH1A1 (0.39) MAPTALDH1A1HPGDNPSR1DHODH
SCHEMBL7490727 0.79 L3MBTL1 (0.36) MAPTALDH1A1DHODHMGLLSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed